View Author
survival disease patient creutzfeldt –jakob disease codon onset study codon 129 creutzfeldt prion signi table –jakob protein gender month variant cjd genotype mutation analysis atopic eczema infant surveillance country prpsc effect variant signi ficance valine homozygote cases signi ficantly prpsc type fluence homozygote number valine germany department eczema prnp gene group iatrogenic distribution codon 129 genotype duration codon 129 polymorphism polymorphism atopic 14-3-3 methionine brain model variable neurol crude creutzfeldt-jakob disease v 210i patients wilcoxon test multivariate prion protein gene health 10 years analyses ficantly university ficant fi ndings e 200k 50 years 14-3-3 test spongiform multivariate analysis prion diseases vlbw infants reference valine homozygotes ficance predictor nding subtype therapy
2 Most Recent Publications
|
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies.
(Article)
Pocchiari, M. Puopolo, M. Brandel, J-P. Alperovitch, A. Zerr, I. Poser, S. Kretzschmar, H.A. Ladogana, A. Rietvald, I. Mitrová, E. Martinez-Martin, P. Pedro-Cuesta, J. de Croes, E.A. Glatzel, M. Cooper, S. Mackenzie, J. Duijn, C.M. van Will, R.G. Aguzzi, A. Budka, H. Gelpi, E. Collins, S.J. Lewis, V. Sutcliffe, T. Guilivi, A. Delasnerie-Laupretre, N. |
2004-10-01
|
|
Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease
(Letter To Editor)
Alperovitch, A. Zerr, I. Pocchiari, M. Mitrová, E. Pedro-Cuesta, J. de Hegyi, I. Collins, S.J. Kretzschmar, H. Duijn, C.M. van Will, R.G. |
1999-01-01
|